Zydus Lifesciences Limited (ZYDUSLIFE) announces positive topline results from completed EVIDENCES-X Phase II(b) clinical trial for Saroglitazar Mg in MASH.
Emcure Pharmaceuticals Limited (EMCURE) expands Poviztra® for MASH treatment, addressing unmet medical needs for metabolic dysfunction-associated steatohepat.